KCI’s V.A.C.Via™ Therapy System Named a Leading Innovation by Podiatry Today
KCI today announced that its V.A.C.Via™ Therapy System was named one of the "Top Ten Innovations in Podiatric Technology" by trade publication Podiatry Today.
SAN ANTONIO—Sept. 7, 2011— Kinetic Concepts, Inc. (NYSE:KCI) today announced that its V.A.C.Via™ Therapy System was named one of the "Top Ten Innovations in Podiatric Technology" by trade publication Podiatry Today.
Podiatry Today ranked V.A.C.Via™ second among innovative devices for its quarter-sized, virtually silent pump that makes it a patient-friendly treatment option. The publication also recognized V.A.C.Via™ System's seven-day performance on one battery charge, as opposed to heavy NiCd rechargeable batteries found in other NPWT devices, as another factor leading to its innovative ranking.
The V.A.C.Via™ Therapy System is a next-generation negative pressure wound therapy (NPWT) solution that offers clinicians and patients an off-the-shelf, portable healing technology that delivers all of the benefits of V.A.C.® Therapy. The technology provides a wound healing environment for low- to moderate-exudating wounds while offering simplicity, mobility and convenience to both physicians and patients.
"Miniaturizing V.A.C.® Therapy in the form of the V.A.C.Via™ System ensures trusted, cost-effective outcomes with added mobility," said Mike Genau, global president, KCI's Active Healing Solutions™. "Helping patients return to their normal routine, while receiving world-class wound care takes industry leading research and developers who put patients first — that is at the heart of what we do at KCI."
The publication also highlights the V.A.C.Via™ System's small size, light weight and portability, with one physician remarking that it can be discreetly attached to a patient's waist throughout the duration of treatment, then recycled or disposed of by the patient at the end of seven days.
For more information please visit www.vacvia.com or www.kci1.com.
Kinetic Concepts, Inc. (NYSE:KCI) is a leading global medical technology company devoted to the discovery, development, manufacture and marketing of innovative, high-technology therapies and products for the wound care, tissue regeneration and therapeutic support system markets. Headquartered in San Antonio, Texas, KCI's success spans more than three decades and can be traced to a history deeply rooted in innovation and a passion for significantly improving the healing and the lives of patients around the world. The company employs approximately 7,100 people and markets its products in more than 20 countries. For more information about KCI and how its products are changing the practice of medicine, visit www.KCI1.com.
FOR MORE INFORMATION, CONTACT: